Skip to main content
Equibles

Bank of New York Mellon Corp

Bank

Position in LCTX — Lineage Cell Therapeutics, Inc.

CIK 1390777 NEW YORK, NY
Back to LCTX Full portfolio

Position in LCTX

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$513,093
+$476,418 QoQ
Shares Held
391,675
+1587.3% QoQ
Ownership
0.155%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 130 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in LCTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. LCTX ranks #240 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,672,623 $830,842,010
2 REGN
Regeneron Pharmaceuticals, Inc.
 758,492 $472,950,091
3 JAZZ
Jazz Pharmaceuticals plc
 1,578,013 $380,253,782
4 ALNY
Alnylam Pharmaceuticals, Inc.
 492,071 $148,128,128
5 INSM
INSMED Inc
 1,312,756 $139,966,036
6 MRNA
Moderna, Inc.
 1,701,675 $119,168,293
7 RVMD
Revolution Medicines, Inc.
 601,056 $112,565,759
8 INCY
Incyte Corp
 972,825 $110,279,435

All Filings in LCTX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $513,093 391,675
2026-03-31 $36,675 23,213
2025-12-31 $38,765 23,213
2025-09-30 $52,615 31,134
2025-06-30 $16,193 17,795
2025-03-31 $152,020 337,827
2024-12-31 $168,913 337,827
2024-09-30 $307,321 337,717
2024-06-30 $435,958 435,958
2024-03-31 $475,369 321,196
2023-12-31 $390,366 358,136
2023-09-30 $421,094 356,861
2023-06-30 $503,173 356,861
2023-03-31 $106,241 70,828
2022-12-31 $82,868 70,828
2022-09-30 $80,034 70,827
2022-06-30 $111,906 70,827
2022-03-31 $632,777 410,895
2021-12-31 $1,032,046 421,244
2021-09-30 $1,071,021 425,009
2021-06-30 $1,086,461 381,215
2021-03-31 $171,312 72,899
2020-12-31 $144,011 81,825
2020-09-30 $74,151 78,885
2020-06-30 $68,629 78,885
2020-03-31 $340,701 410,485